Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”

Abstract
Recently, Klis et al. conducted an audit of Buruli ulcer case record forms of patients managed under routine care conditions in a Buruli ulcer treatment center and showed a surprisingly high rate (54%) of noncompliance with therapy (1). Incomplete adherence to treatment has been identified as the most serious problem in tuberculosis control (2) and a major obstacle to the elimination of the disease (3). To ensure adherence to therapy in our study, several approaches were incorporated into patient care. These included issuing medication in 2-weekly batches, allowing the clinician several opportunities to assess adherence during therapy.
Description
An article published by Antimicrobial Agents and Chemotherapy and available at doi:10.1128/AAC.03874-14
Keywords
Citation
Antimicrobial Agents and Chemotherapy Volume 58 Number 10
Collections